OESO-SEMPIRE 17th World Conference | Esophagus 2026 Versailles | June 14-17, 2026
Session 33: Challenging Cases in Oncology
Wednesday, June 17, 2:00 – 3:30 am
Auditorium Condé
- HER2-Targeted Therapies: new upcoming trials
- Role of Immunotherapy for long-term survivorship
- Claudin 18.2 Therapies for Gastroesophageal Cancer: full remission possible?
- TNT a new option?
- CtDNA guidance?: PLAGAST and more
- Lung metastases: important or not?
- Thinking out of the box with localized disease
- When de-escalation after first line?
- liver limited disease: resect metastases like in colon cancer?
- Surveillance after “cure”